ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Alto Neuroscience Inc

Alto Neuroscience Inc (ANRO)

9.96
0.12
(1.22%)
Closed 27 June 6:00AM
9.96
0.00
( 0.00% )
Pre Market: 10:13PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
9.96
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
9.40 52 Week Range 24.00
Market Cap
Previous Close
9.96
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
98,392
Shares Outstanding
26,883,990
Dividend Yield
-
PE Ratio
-7.38
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-36.31M

About Alto Neuroscience Inc

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was US$9.96. Over the last year, Alto Neuroscience shares have traded in a share price range of US$ 9.40 to US$ 24.00.

Alto Neuroscience currently has 26,883,990 shares in issue. The market capitalisation of Alto Neuroscience is US$267.76 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -7.38.

ANRO Latest News

Alto Neuroscience Initiates Phase 2 Study of ALTO-101, a Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia

– ALTO-101 has been shown to positively impact cognition and key cognition-related EEG markers in humans when delivered orally – – Novel transdermal formulation of ALTO-101 exhibited favorable...

Amit Etkin, M.D., Ph.D., Founder and CEO of Alto Neuroscience, Named an EY Entrepreneur Of The Year® 2024 Bay Area Award Winner

– Dr. Etkin recognized as a Bay Area winner out of 26 finalists by an independent panel of judges – – Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future across...

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York...

Alto Neuroscience Appoints Michael Hanley as Chief Operating Officer

– Mr. Hanley brings over two decades of leadership experience in product development and commercialization across a wide range of neuropsychiatric indications, including major depressive disorder...

Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights

– Initiated Phase 2 study of ALTO-203 in patients with MDD and anhedonia – – Reported positive Phase 1 data with transdermal formulation of novel PDE4 inhibitor, ALTO-101; achieved significantly...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.34-11.858407079611.311.629.413393010.50817538CS
4-2.75-21.636506687612.7112.789.410361811.20442683CS
12-4.08-29.059829059814.0416.5359.49839212.80488716CS
26-12.04-54.727272727322249.418494615.19363147CS
52-12.04-54.727272727322249.418494615.19363147CS
156-12.04-54.727272727322249.418494615.19363147CS
260-12.04-54.727272727322249.418494615.19363147CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HYTOHyTerra Ltd
AUD 0.017
(142.86%)
3.9M
BPHOBBPH Energy Limited
AUD 0.003
(50.00%)
3.68M
HTGHarvest Technology Group Limited
AUD 0.021
(50.00%)
1.36M
VSROVoltaic Strategic Resources Ltd
AUD 0.003
(50.00%)
2.02M
EELENRG Elements Ltd
AUD 0.003
(50.00%)
50k
AS2OAskari Metals Ltd
AUD 0.001
(-66.67%)
583.46k
TKMOTrek Metals Limited
AUD 0.001
(-66.67%)
277.78k
CAIOACalidus Resources Limited
AUD 0.001
(-66.67%)
238.1k
PAROParadigm Biopharmaceuticals Limited
AUD 0.005
(-64.29%)
346.94k
CNJConico Ltd
AUD 0.001
(-50.00%)
60.09k
MAYMelbana Energy Limited
AUD 0.033
(-45.00%)
101.05M
SYASayona Mining Limited
AUD 0.037
(5.71%)
61.09M
IMMImmutep Limited
AUD 0.34
(-20.47%)
50.2M
REDRed 5 Limited
AUD 0.37
(-0.67%)
49.12M
ME1Melodiol Global Health Ltd
AUD 0.003
(-25.00%)
34.29M

Discussion

View Full Feed
threebabiesbusy threebabiesbusy 5 minutes ago
I wish I had more of the legal background to interpret these legal docs
FSRNQ
TheFinalCD TheFinalCD 5 minutes ago
16.89 algos dropped it on solid news to 15.95 https://x.com/READY_2_PROFIT/status/1806312414142414914
CLSK
Donotunderstand Donotunderstand 5 minutes ago
So this open may allow you time to make up the Wed loss
NKLA
mike_dotcom mike_dotcom 5 minutes ago
Looking more like the Challenger.
AVXL
Buckey Buckey 5 minutes ago
based on purely what I see the speculator pump and dumpers are playing naz afterhours markets and in particular premarket ridiculous volumes
learningcurve2020 learningcurve2020 5 minutes ago
BioHarm doesn't want to chime in on this one. A "Little company" able to handle all that complex manufacturing, and on two continents yet!!! Eye rolls.
NWBO
sirant sirant 5 minutes ago
I believe your right BIG things coming. JMHO

GO $MCIC
MCIC
DiscoverGold DiscoverGold 5 minutes ago
Today Salesforce.com Inc. (CRM) is the best performer in the DJIA
By: Thom Hartle | June 27, 2024

• Today (8:32 CST), the best performer in the DJIA is Salesforce.com Inc. CRM.

pbs.twimg.com/media/GRFWRM5WYAAEMlx?format=png&name=900x900

https
CRM
golf stud golf stud 5 minutes ago
I’ll let the more knowledgeable posters that understand this better reply if they would like. My view is if amarin wins generics can’t sell in the cvd space or they will be subject to fines and I’ll go with Marjac and his thinking on this one .
AMRN
jtsmgoblue jtsmgoblue 5 minutes ago
Haha, 300k+ shares and grateful to assholes like you and your squad.
AVXL
totffe totffe 6 minutes ago
Indeed. The potential here is enormous. 24 up!
EMGE
kbaz kbaz 6 minutes ago
I did Some Research and Speculate that you have been Filling your Trading Account with This Monkey Trap POS SFIO from $.08 down to $.008.... So Having these YUUUUUGE Losses, Has Got you Conflicted with Reality. I would Blame JETH's for Scamming Everyone like you, Except that The World will Ge
SFIO
Carjockey2 Carjockey2 6 minutes ago
I guess so, but like I posted, we filed this motion...
FSRNQ
I-Glow I-Glow 6 minutes ago
But you don't seem to understand that LCY doesn't owe bioaq shareholders anything.

The Common shareholders aren't entitled to paid more than the secured and unsecured creditors.

Read the SEC warnings about investing Q stocks.

There isn't any chance that t
wickw50 wickw50 6 minutes ago
archilles, The fact that the trade was $.0002 below the Bid at that time was not very encouraging. Had it been for $.0002 above the Ask, that could have been deemed encouraging. jmho
ENZC
weedtrader420 weedtrader420 6 minutes ago
SUKU BITCOIN SNAP! THE POWER $100K TARGET XRP🫲🤑☝️
BTCUSD
pos_stock_hoarder pos_stock_hoarder 6 minutes ago
https://t4.ftcdn.net/jpg/00/24/23/05/240_F_24230593_MQxt3VdMo5rBpAdTdCYluJAfuIquTajg.jpg
Grip it and Sip It Grip it and Sip It 7 minutes ago
Meh- I might welch too! Just a matter of time. None of you have honor when you say you won’t honor the bet a week ago
CYDY
TJG TJG 7 minutes ago
Can we GAP UP this AM I wonder

https://www.youtube.com/watch?v=lITBGjNEp08
AFFU
stockanalyze stockanalyze 7 minutes ago
you and your other hedge fund traders are responsible for the delay. you bought in 2014 knowing of nws. what the hell you are crying about? folks like me who bought pre 2008 as well as added pre nws should be compensated first even though i had to sell my shares due to financial need. do you get the
FNMA
NASDAQ2020 NASDAQ2020 7 minutes ago
Safe travels.
ELTP
sirant sirant 7 minutes ago
GOOD MORNING EVERYONE

GO $MCIC
MCIC
DiscoverGold DiscoverGold 7 minutes ago
The 10 Top/Bottom NASDAQ 100 Index percent net change performers
By: Thom Hartle | June 27, 2024

• Today (8:34 CST), the 10 top/bottom percent net change performers in the NASDAQ 100 Index.

pbs.twimg.com/media/GRFWiRBWAAA5Vy4?format=png&name=900x900
Dj56 Dj56 7 minutes ago
So any spike in sp on filings complete and approved, or other news, WILL RESULT IN A DIP SIGNIFICANTBENOUGH FORVA SELL SOME STOCK AND Wit to buy the dip if you want to add 'free' shares?
RSPI

Your Recent History

Delayed Upgrade Clock